{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:58:51Z","timestamp":1792807131871,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031370","name":"Taysha Gene Therapies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM144927"],"award-info":[{"award-number":["T32GM144927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007737"],"award-info":[{"award-number":["T32HL007737"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007281"],"award-info":[{"award-number":["T32AI007281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS121718"],"award-info":[{"award-number":["R01 NS121718"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.eplepsyres.2025.107514","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T11:09:23Z","timestamp":1738321763000},"page":"107514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["4-Phenylbutyrate restored GABA uptake, mitigated seizures in SLC6A1 and SLC6A11 microdeletions\/3p- syndrome: From cellular models to human patients"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-016X","authenticated-orcid":false,"given":"Melissa B.","family":"DeLeeuw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangzhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma","family":"Randhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Qiong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.eplepsyres.2025.107514_bib1","doi-asserted-by":"crossref","first-page":"19250","DOI":"10.1074\/jbc.M117.797092","article-title":"Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile\/juvenile parkinsonism","volume":"292","author":"Asjad","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107514_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107514_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of gaba during development: the nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112973","article-title":"A missense mutation in SLC6A1 associated with Lennox-Gastaut syndrome impairs GABA transporter 1 protein trafficking and function","volume":"320","author":"Cai","year":"2019","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.eplepsyres.2025.107514_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajhg.2015.02.016","article-title":"Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures","volume":"96","author":"Carvill","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fped.2014.00070","article-title":"GABAergic signaling as therapeutic target for autism spectrum disorders","volume":"2","author":"Cellot","year":"2014","journal-title":"Front. Pediatr."},{"issue":"12","key":"10.1016\/j.eplepsyres.2025.107514_bib7","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1523\/JNEUROSCI.3364-04.2005","article-title":"GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum","volume":"25","author":"Chiu","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107514_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H","article-title":"Neuronal and glial localization of GAT-1, a high-affinity \u03b3-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex","volume":"396","author":"Conti","year":"1998","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107514_bib9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(97)00414-4","article-title":"Immunoreactivity for the GABA transporter-1 and GABA transporter-3 is restricted to astrocytes in the rat thalamus. A light and electron-microscopic immunolocalization","volume":"83","author":"De","year":"1998","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.eplepsyres.2025.107514_bib10","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/ajmg.a.36761","article-title":"3p25. 3 microdeletion of GABA transporters SLC6A1 and SLC6A11 results in intellectual disability, epilepsy and stereotypic behavior","volume":"164","author":"Dikow","year":"2014","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"21","key":"10.1016\/j.eplepsyres.2025.107514_bib11","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/ajmg.a.32533","article-title":"Molecular characterization of a patient with 3p deletion syndrome and a review of the literature","volume":"146","author":"Fernandez","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.eplepsyres.2025.107514_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.834498","article-title":"Molecular and clinical repercussions of GABA transporter 1 variants gone amiss: links to epilepsy and developmental spectrum disorders","volume":"9","author":"Fischer","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.618059","article-title":"Case report: a case report and literature review of 3p deletion syndrome","volume":"9","author":"Fu","year":"2021","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107514_bib14","doi-asserted-by":"crossref","first-page":"fcaa170","DOI":"10.1093\/braincomms\/fcaa170","article-title":"Current knowledge of SLC6A1-related neurodevelopmental disorders","volume":"2","author":"Goodspeed","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib15","article-title":"4-Phenylbutyrate for STXBP1 and SLC6A1. Safety, tolerability, seizure, and EEG outcomes. A case series at 2 centers","author":"Grinspan","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.eplepsyres.2025.107514_bib16","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1152\/jn.00240.2003","article-title":"GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus","volume":"90","author":"Jensen","year":"2003","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107514_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/epi.13986","article-title":"Defining the phenotypic spectrum of SLC6A1 mutations","volume":"59","author":"Johannesen","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107514_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eplepsyres.2017.08.013","article-title":"Defects at the crossroads of GABAergic signalling in generalized genetic epilepsies","volume":"137","author":"Kang","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10803-012-1543-7","article-title":"A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA a receptors","volume":"43","author":"Kang","year":"2013","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"37","author":"Laxer","year":"2014","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107514_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-005-0017-9","article-title":"GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus","volume":"111","author":"Lee","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107514_bib22","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/epi.14531","article-title":"SLC6A1 variants identified in epilepsy patients reduce \u03b3-aminobutyric acid transport","volume":"59","author":"Mattison","year":"2018","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.eplepsyres.2025.107514_bib23","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/brain\/awab207","article-title":"Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons","volume":"144","author":"Mermer","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2025.107514_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105810","article-title":"Astrocytic GABA transporter 1 deficit in novel SLC6A1 variants mediated epilepsy: connected from protein destabilization to seizures in mice and humans","volume":"172","author":"Mermer","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107514_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.1320350225","article-title":"Loss of the 3p25. 3 band is critical in the manifestation of del (3p) syndrome: Karyotype-phenotype correlation in cases with deficiency of the distal portion of the short arm of chromosome 3","volume":"35","author":"Narahara","year":"1990","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107514_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac144","article-title":"4-Phenylbutyrate restored \u03b3-aminobutyric acid uptake and reduced seizures in SLC6A1 patient variant-bearing cell and mouse models","volume":"4","author":"Nwosu","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113723","article-title":"Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD","volume":"342","author":"Poliquin","year":"2021","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107514_bib28","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.3390\/ijms25094601","article-title":"Modulating endoplasmic reticulum chaperones and mutant protein degradation in GABRG2(Q390X) associated with genetic epilepsy with febrile seizures plus and dravet syndrome","volume":"25","author":"Poliquin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107514_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00441-004-0928-0","article-title":"Differential expression of the GABA transporters GAT-1 and GAT-3 in brains of rats, cats, monkeys and humans","volume":"320","author":"Pow","year":"2005","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107514_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#","article-title":"GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus","volume":"367","author":"Ribak","year":"1996","journal-title":"J. Comp. Neurol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107514_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370221989263","article-title":"Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance","volume":"246","author":"Sears","year":"2021","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107514_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/epi.17779","article-title":"4-Phenylbutyrate promoted wild-type \u03b3-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2+\u2009\/Q390X mice associated with Dravet syndrome","volume":"65","author":"Shen","year":"2024","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107514_bib33","doi-asserted-by":"crossref","first-page":"fcae110","DOI":"10.1093\/braincomms\/fcae110","article-title":"\u03b3-Aminobutyric acid transporter and GABAA receptor mechanisms in Slc6a1+\u2009\/A288V and Slc6a1+\u2009\/S295L mice associated with developmental and epileptic encephalopathies","volume":"6","author":"Shen","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.eplepsyres.2025.107514_bib34","doi-asserted-by":"crossref","unstructured":"Verjaal, M., & De Nef, M.B. 1978. A patient with a partial deletion of the short arm of chromosome.","DOI":"10.1001\/archpedi.1978.02120260045012"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107514_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13041-020-00612-6","article-title":"Endoplasmic reticulum retention and degradation of a mutation in SLC6A1 associated with epilepsy and autism","volume":"13","author":"Wang","year":"2020","journal-title":"Mol. Brain"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:37:14Z","timestamp":1778701034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":35,"alternative-id":["S0920121125000154"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107514","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Phenylbutyrate restored GABA uptake, mitigated seizures in SLC6A1 and SLC6A11 microdeletions\/3p- syndrome: From cellular models to human patients","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107514"}}